Abstract—From a network medicine perspective, diseases are caused by perturbations in the dynamics of multiple interacting genes - a disease module. A drug that is a suitable candidate for re-purposing, should affect perturbed disease modules other than the one for which it was designed. In other words, it must act on various disease modules. A systematic analysis of re purposing suitability requires deeper understanding of drug target modularity. In this paper, we present a large-scale analysis of drug-target relationships, evaluating the locality of drug targets in protein-protein interaction networks. We show that the various drugs in each category affect different regions in biological networks, and present modular features. Additionall...
Abstract Background Diverse interactions occur between biomolecules, such as activation, inhibition,...
Abstract Drug combination is becoming a popular strategy for combating complex traits, where combina...
Drug repositioning, or the identification of new indications for known drugs, is a useful strategy f...
In this paper we perform an exploratory analysis of the genotypic and genotypic relation between dru...
<div><p>The interaction environment of a protein in a cellular network is important in defining the ...
Drug repurposing strategy, proposing a therapeutic switching of already approved drugs with known me...
Drug repurposing strategy, proposing a therapeutic switching of already approved drugs with known me...
The interaction environment of a protein in a cellular network is important in defining the role tha...
Drugs bind to their target proteins, which interact with downstream effectors and ultimately perturb...
Drugs bind to their target proteins, which interact with downstream effectors and ultimately perturb...
Network-based methods are playing an increasingly important role in drug design. Our main question i...
In this work, we performed an analysis of the networks of interactions between drugs and their targe...
Due to intrinsic complex molecular interactions, the “one disease – one target – one drug” strategy ...
The increasing cost of drug development together with a significant drop in the number of new drug a...
Despite considerable progress in genome- and proteome-based high-throughput screening methods and in...
Abstract Background Diverse interactions occur between biomolecules, such as activation, inhibition,...
Abstract Drug combination is becoming a popular strategy for combating complex traits, where combina...
Drug repositioning, or the identification of new indications for known drugs, is a useful strategy f...
In this paper we perform an exploratory analysis of the genotypic and genotypic relation between dru...
<div><p>The interaction environment of a protein in a cellular network is important in defining the ...
Drug repurposing strategy, proposing a therapeutic switching of already approved drugs with known me...
Drug repurposing strategy, proposing a therapeutic switching of already approved drugs with known me...
The interaction environment of a protein in a cellular network is important in defining the role tha...
Drugs bind to their target proteins, which interact with downstream effectors and ultimately perturb...
Drugs bind to their target proteins, which interact with downstream effectors and ultimately perturb...
Network-based methods are playing an increasingly important role in drug design. Our main question i...
In this work, we performed an analysis of the networks of interactions between drugs and their targe...
Due to intrinsic complex molecular interactions, the “one disease – one target – one drug” strategy ...
The increasing cost of drug development together with a significant drop in the number of new drug a...
Despite considerable progress in genome- and proteome-based high-throughput screening methods and in...
Abstract Background Diverse interactions occur between biomolecules, such as activation, inhibition,...
Abstract Drug combination is becoming a popular strategy for combating complex traits, where combina...
Drug repositioning, or the identification of new indications for known drugs, is a useful strategy f...